Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-928-3 | CAS number: 68630-95-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Eye irritation - Interpretation of Results following Prediction Model
• A test item is considered to be irritant to the eye (i.e. would require labelling as either GHS 1 or 2) if the eye model viability after exposure and post-treatment incubation is ≤60%.
• A test item is considered as a non-irritant to the eye (i.e. would not require a warning label in the European chemical classification systems) if the eye model viability after exposure and post-treatment incubation is >60%.
The current assay is not intended to differentiate between GHS class 1 and GHS class 2 or R36 and R41 (degree of stromal damage).
The percentage of viability obtained with test item Crodateric CYAP-100 was 97.3%, therefore it has to be considered as Non- Irritant to the eye.
Skin Irritation -
The skin irritation potential of Crodateric CYAP-100 was assessed in vitro according to OECD Test Guideline 439: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method.
After a 65 minute exposure on the surface of the EpiDermTM reconstructed human epidermis and a 42 ± 4h post-exposure incubation time, viability of the tissues was assessed and compared to the negative control. The percentage of viability obtained was 4.816 % and therefore since the test item reduced the viability to below 50% it should be considered as Irritant to the skin.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- “EpiDermTM In vitro Reconstructed Human Epidermis Skin Irritation Test (OECD 439 28 Jul 2015 and is based on the MatTek protocol (MK-24-007-0023, 11 July 14) using the MatTek Corporation EpiDermTM reconstructed tissue model EPI-200
- GLP compliance:
- yes (incl. QA statement)
- Specific details on test material used for the study:
- Supplier Croda
Test Item name Crodateric CYAP-100
Supplier Code DEV080817DS3
Supplier batch/lot number PS-196-562
CAS number 70983-43-6
Purity 99.41% (from CofA)
Expiry Date 3 July 2018
Physical state Solid, Dark
Storage Conditions Room Temperature - Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: cultured
- Justification for test system used:
- The reconstructed human epidermal model EpiDermTM (EPI-200-MatTek Corporation) consists of normal human-derived epidermal keratinocytes which have been cultured to form a multi-layered highly differentiated model of the human epidermis. It consists of organised basal, spinous and granular layers and a multi-layered stratum corneum containing intercellular lamellar lipid layers arranged in patterns analogous to those found in vivo.
Initially the predictive capacity of the modified EpiDerm™ Skin Irritation Test (SIT) test method, using MatTek EpiDermTM tissue model EPI-200, underwent full prospective validation from 2003-2007. The test method components of this method were used to define the essential test methods components of the original and updated ECVAM Performance Standards (PS).
A modification of the original EpiDerm™ SIT was validated using the original ECVAM PS in 2008. In 2008, ESAC concluded that the Modified EpiDerm™ SIT has sufficient accuracy and reliability for prediction of R38 skin irritating and no-label (non-skin irritating) test substances - Vehicle:
- unchanged (no vehicle)
- Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- After pre-wetting tissues with 25µl DPBS (Sterile Dulbecco’s Phosphate Buffered Saline), single topical application of nominal 25mg neat test item, 30µl of negative control (DPBS) or positive control (SDS 5%) to the surface of the EpiDermTM model for a set time.
- Duration of treatment / exposure:
- 60 ± 1 minute* (25 minutes* at room temperature and 35 minutes at 37°C, 5% CO2, ≥95% Relative Humidity (RH)), followed by 42 ± 4h post-treatment incubation, prior to the MTT endpoint; three tissues per condition (n=3)
- Duration of post-treatment incubation (if applicable):
- 42 ± 4h post-treatment incubation
- Number of replicates:
- 3
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- Percentage of viability (relative to negative control)
- Value:
- 4.816
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Interpretation of results:
- Category 2 (irritant) based on GHS criteria
- Conclusions:
- The skin irritation potential of Crodateric CYAP-100 was assessed in vitro according to OECD Test Guideline 439: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method.
After a 65 minute exposure on the surface of the EpiDermTM reconstructed human epidermis and a 42 ± 4h post-exposure incubation time, viability of the tissues was assessed and compared to the negative control. The percentage of viability obtained was 4.816 % and therefore since the test item reduced the viability to below 50% it should be considered as Irritant to the skin.
Reference
Mean and SD of cell viability measurements and of viability percentages after 65 min of application and 42h (± 4h) post-incubation.
Name |
Code |
Mean of OD |
SD of OD |
Mean of viability (%) |
SD of viability (%) |
CV % |
Classification |
DPBS |
NC |
1.514 |
0.079 |
100.000 |
5.243 |
5.243 |
Non-Irritant |
SDS 5% |
PC |
0.077 |
0.018 |
5.097 |
1.176 |
23.064 |
Irritant |
Crodateric CYAP-100 |
TA1 |
0.082 |
0.017 |
5.427 |
1.096 |
20.191 |
Irritant |
NC: Negative control (DPBS), PC: Positive control (SDS 5%), TA1: Crodateric CYAP-100.
Prediction model of irritancy: test items that reduce the viability to 50% or below are irritant (I), test items with a percentage viability above 50% are considered to be non-irritant (NI).
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- The detailed method followed in this study is described in XCellR8 SOP L0069: ‘EpiOcularTM Eye Irritation Test (OECD TG492) and is based on the MatTek protocol (MK-24-007-0055, 10 Feb 17) using the MatTek Corporation EpiOcularTM reconstructed tissue model OCL-200. This protocol was approved as the new OECD TG492 at the 2015 meeting of the OECD Working Group of the National Coordinators for the Test Guidelines Programme
- GLP compliance:
- yes (incl. QA statement)
- Specific details on test material used for the study:
- Supplier Croda
Test Item Name Crodateric CYAP-100
Supplier Code DEV080817DS3
Supplier batch/lot number PS-196-562
CAS number 70983-43-6
Purity 99.41% (from Sponsor Certificate of Analysis)
Expiry Date 3 July 2018
Physical state Solid, Dark, Brown
Storage Conditions Room Temperature
Solubility N/A - neat application
Administration method Topical application
Concentration tested Neat
XCellR8 test item code CRO1026
Study test item code TA1 - Species:
- human
- Strain:
- other: reconstructed tissue. MatTek’s EpiOcularTM system consists of normal, human-derived keratinocytes which have been cultured to form a stratified, squamous epithelium similar to that found in the cornea.
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- After pre-wetting tissues with 20µl PBS (Sterile Dulbecco’s Phosphate Buffered Saline) for 30 ± 2 min, single topical application of nominal 50mg of neat test item, using a pin applicator or 50µl of reference items to the surface of the EpiOcularTM model for 6h ± 15 minutes, followed by a 25 ± 2 minutes’ post-treatment immersion, and 18 hours ± 15 minutes’ post-treatment incubation, prior to the MTT endpoint; three tissues per condition (n=3).
- Duration of treatment / exposure:
- After pre-wetting tissues with 20µl PBS (Sterile Dulbecco’s Phosphate Buffered Saline) for 30 ± 2 min, single topical application of nominal 50mg of neat test item, using a pin applicator or 50µl of reference items to the surface of the EpiOcularTM model for 6h ± 15 minutes, followed by a 25 ± 2 minutes’ post-treatment immersion, and 18 hours ± 15 minutes’ post-treatment incubation, prior to the MTT endpoint; three tissues per condition (n=3).
- Details on study design:
- The EpiOcularTM tissue model (OCL-200-MatTek Corporation) is composed of stratified human keratinocytes in a three-dimensional structure, reflecting the morphology and function of the human corneal epithelium found in vivo.
The EpiOcular™ Eye Irritation Test (EIT), using the MatTek EpiOcularTM tissue model OCL-200, was validated by the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) and Cosmetics Europe between 2008 and 2013. From this validation study and its independent peer review it was concluded that the EpiOcularTM EIT is able to correctly identify chemicals (both substances and mixtures) not requiring classification and labelling for eye irritation or serious eye damage according to UN GHS, and the test method was recommended as scientifically valid for that purpose, as an alternative to Draize Rabbit Eye Test with excellent correlation -In vivo to In vitro test results. - Irritation parameter:
- other: percentage of viability
- Run / experiment:
- The test item Crodateric CYAP-100 did not reduce the viability to 60% or below after 6h of application and should be considered as non-Irritant to the eye.
- Value:
- 97.3
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- Prior to the study, the required compatibility checks (as per SOP L0069) show that the test item did interfere with MTT. However, OD obtained with the freeze-killed tissues were low (<0.1) and therefore they were not subtracted from OD values obtained during the main assay.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Interpretation of Results following Prediction Model
• A test item is considered to be irritant to the eye (i.e. would require labelling as either GHS 1 or 2) if the eye model viability after exposure and post-treatment incubation is ≤60%.
• A test item is considered as a non-irritant to the eye (i.e. would not require a warning label in the European chemical classification systems) if the eye model viability after exposure and post-treatment incubation is >60%.
The current assay is not intended to differentiate between GHS class 1 and GHS class 2 or R36 and R41 (degree of stromal damage).
The percentage of viability obtained with test item Crodateric CYAP-100 was 97.3%, therefore it has to be considered as Non- Irritant to the eye.
Reference
Mean and SD of viability measurements and of viability percentages after 6h (± 15 min) of application and 18h (± 15 min) post-incubation.
Name |
Code |
mean of OD |
SD of OD |
Mean of viability (%) |
SD of viability (%) |
CV % |
Classification |
Sterile water |
NC |
1.421 |
0.068 |
100.0 |
4.8 |
4.8 |
Non-Irritant |
Methyl Acetate |
PC |
0.035 |
0.025 |
2.4 |
1.7 |
71.6 |
Irritant |
CRODATERIC CYAP-100 |
TA1 |
1.383 |
0.098 |
97.3 |
6.9 |
7.1 |
Non-Irritant |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
Justification for classification or non-classification
The % viability results obtained for this substance by in-vitro eye irritancy testing gave a value of 97.3%, which is much higher than the <60% value required to classify as an irritant.Therefore this substance does not meet the GHS criteria for classification for eye irritancy.
However the % viability result for skin irritation was 4.816 % and therefore since the test item reduced the viability to well below 50% and according to this in-vitro method it does meet the GHS criteria for classification and is considered as an Irritant to the skin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
